Literature DB >> 24476556

Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.

Rolando Vernal1, Jaime Díaz-Zúñiga, Samanta Melgar-Rodríguez, Myriam Pujol, Eva Diaz-Guerra, Augusto Silva, Mariano Sanz, Jose A Garcia-Sanz.   

Abstract

AIM: Destructive periodontitis is associated with a Th1-Th17 immune response and activation of RANKL-induced osteoclasts. In addition, Porphyromonas gingivalis K1 and K2 serotypes induce a strong Th1-Th17 response. This study aimed to investigate whether these P. gingivalis serotypes induce higher osteoclasts activation, by increased Th17-associated RANKL production, and an antigen-specific memory T-lymphocyte response.
MATERIAL AND METHODS: The RANKL production and TRAP(+) osteoclast induction were quantified on naïve T lymphocytes stimulated with dendritic cells primed with the P. gingivalis serotypes. The T-bet, GATA-3, RORC2 and Foxp3 expression was correlated with RANKL production. The frequency of proliferating memory T lymphocytes in response to P. gingivalis serotypes was determined in both periodontitis and healthy subjects.
RESULTS: T lymphocytes stimulated by K1 or K2-primed dendritic cells elicited higher levels of RANKL and TRAP(+) osteoclasts than cells stimulated with the other serotypes. RANKL positively correlated with RORC2. Whereas periodontitis patients had a higher frequency of memory T lymphocytes responding to K1 or K2, healthy subjects had a higher frequency of memory T lymphocytes responding to K4 or K(-) .
CONCLUSIONS: P. gingivalis serotypes K1 and K2, but not others, are associated with an increased production of the osteoclastogenesis-related factor RANKL. This important information suggests that these serotypes could elicit a greater bone resorption in vivo and have a role in the periodontitis pathogenesis.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Porphyromonas gingivalis; RANKL; T lymphocytes; bone resorption; periodontitis; serotypes

Mesh:

Substances:

Year:  2014        PMID: 24476556     DOI: 10.1111/jcpe.12236

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  16 in total

1.  Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes.

Authors:  Francisca Castillo; Gustavo Monasterio; Juan Pablo Ibarra; José Guevara; Emilio A Cafferata; Emiliano Vicencio; Cristian Cortez; Paola Carvajal; Rolando Vernal
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

2.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

3.  Initial changes in alveolar bone volume for sham-operated and ovariectomized rats in ligature-induced experimental periodontitis.

Authors:  Jing Dai; Yihui Ma; Miusi Shi; Zhengguo Cao; Yufeng Zhang; Richard J Miron
Journal:  Clin Oral Investig       Date:  2015-07-17       Impact factor: 3.573

Review 4.  Polarization Profiles of T Lymphocytes and Macrophages Responses in Periodontitis.

Authors:  Franco Cavalla; Marcela Hernández
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Microbiological effects and recolonization patterns after adjunctive subgingival debridement with Er:YAG laser.

Authors:  Ignacio Sanz-Sánchez; Alberto Ortiz-Vigón; David Herrera; Mariano Sanz
Journal:  Clin Oral Investig       Date:  2015-09-30       Impact factor: 3.573

6.  A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

Authors:  Neil M O'Brien-Simpson; James A Holden; Jason C Lenzo; Yan Tan; Gail C Brammar; Katrina A Walsh; William Singleton; Rebecca K H Orth; Nada Slakeski; Keith J Cross; Ivan B Darby; Dorit Becher; Tony Rowe; Adriana Baz Morelli; Andrew Hammet; Andrew Nash; Anna Brown; Bing Ma; Didier Vingadassalom; Jacqueline McCluskey; Harold Kleanthous; Eric C Reynolds
Journal:  NPJ Vaccines       Date:  2016-12-01       Impact factor: 7.344

7.  Periodontal treatment prevents arthritis in mice and methotrexate ameliorates periodontal bone loss.

Authors:  Paul M Lübcke; Meinolf N B Ebbers; Johann Volzke; Jana Bull; Susanne Kneitz; Robby Engelmann; Hermann Lang; Bernd Kreikemeyer; Brigitte Müller-Hilke
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

8.  Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena.

Authors:  Luis González-Osuna; Alfredo Sierra-Cristancho; Carolina Rojas; Emilio A Cafferata; Samanta Melgar-Rodríguez; Angélica M Cárdenas; Rolando Vernal
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 9.  Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies.

Authors:  Carolina Rojas; Michelle P García; Alan F Polanco; Luis González-Osuna; Alfredo Sierra-Cristancho; Samanta Melgar-Rodríguez; Emilio A Cafferata; Rolando Vernal
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 10.  Porphyromonas gingivalis: major periodontopathic pathogen overview.

Authors:  Jaroslav Mysak; Stepan Podzimek; Pavla Sommerova; Yelena Lyuya-Mi; Jirina Bartova; Tatjana Janatova; Jarmila Prochazkova; Jana Duskova
Journal:  J Immunol Res       Date:  2014-03-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.